Document is current
Any future updates will be listed below
-
Authors
Chen, Yun
Zheng, Shan
Zhang, Jiaying
Yao, Shaobo
Miao, Weibing https://orcid.org/0000-0002-0058-4953
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct04499365 at ClinicalTrials.govDocuments that mention this clinical trial
Characterization of the benign lesions with increased 68Ga-FAPI-04 uptake in PET/CT
https://doi.org/10.1007/s12149-021-01673-w
68Ga-DOTA-FAPI-04 PET/CT imaging in radioiodine-refractory differentiated thyroid cancer (RR-DTC) patients
https://doi.org/10.1007/s12149-022-01742-8
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (81971651)
National Natural Science Foundation of China (82171982)
Natural Science Foundation of Fujian (2019J01454)
Natural Science Foundation of Fujian (2020J05249)
Fujian Provincial Health Commission Science and Technology and Programme (2020GGA045)
- License Information
-
More Information
Article History
Received: 23 September 2021
Accepted: 10 April 2022
First Online: 12 May 2022
Declarations
:
: The authors declare that they have no conflict of interest.
: The study was approved by the institutional review board of our hospital and written informed consent for publication of this report was obtained from the patients.
